History
  • No items yet
midpage
A. v. Thang Botanicals, Inc.
3:24-cv-07029
N.D. Cal.
Mar 28, 2025
Read the full case

Background

  • Plaintiffs purchased 7-OH Tablets, a kratom-derived product manufactured by Thang Botanicals, alleging the packaging failed to warn about high addiction risks.
  • Plaintiffs became addicted, suffered withdrawal symptoms, and claimed they would not have purchased the products had they known of the addiction risk.
  • Plaintiffs filed a putative class action, asserting both nationwide and state-specific consumer protection, warranty, unjust enrichment, and fraud claims.
  • Defendants moved to dismiss the complaint and to strike nationwide class allegations, arguing, among other things, lack of standing and failure to state a claim.
  • Plaintiffs conceded certain claims (injunctive relief, False Advertising Law, unjust enrichment), and agreed to limit their claims to California, Oregon, and Nevada.
  • The Court granted Plaintiffs leave to amend most claims, except to add new claims or parties.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Standing for Injunctive Relief Not contested; concede lack of standing Plaintiffs aware of risks, so no standing Dismissed for lack of standing
Duty to Disclose Addiction Risk Omission relates to an unreasonable safety hazard; exclusive knowledge No duty; website/label disclaimer sufficed Sufficiently alleged duty; motion denied
Deception of Reasonable Consumer Packaging misleading for not warning of risks Website disclaimer sufficient for notice Factual question; survives dismissal
Nationwide Class Claims Limited claims to CA, OR, NV Lack standing for nationwide; violates due process Nationwide claims dismissed/struck
FAL & Unjust Enrichment Not opposed; concede Not cognizable, wrong basis Dismissed
Implied Warranty Label omits warning, so not merchantable No affirmative promises on label Dismissed; lack of factual basis
Fraud by Omission Claims under plaintiffs' state law Vague law basis, website gave notice Dismissed for pleading deficiencies

Key Cases Cited

  • Khoja v. Orexigen Therapeutics, Inc., 899 F.3d 988 (9th Cir. 2018) (sets standards for judicial notice and incorporation by reference)
  • Spokeo, Inc. v. Robins, 578 U.S. 330 (2016) (defines Article III standing requirements)
  • Williams v. Gerber Prods. Co., 552 F.3d 934 (9th Cir. 2008) (motion to dismiss consumer claims is rare; reasonable consumer standard)
  • Lee v. City of Los Angeles, 250 F.3d 668 (9th Cir. 2001) (incorporation by reference doctrine)
  • Ashcroft v. Iqbal, 556 U.S. 662 (2009) (pleading standards)
  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (plausibility standard)
  • Warth v. Seldin, 422 U.S. 490 (1975) (federal jurisdiction and standing requirements)
  • Foman v. Davis, 371 U.S. 178 (1962) (leave to amend factors)
  • Lopez v. Smith, 203 F.3d 1122 (9th Cir. 2000) (presumption in favor of granting leave to amend)
Read the full case

Case Details

Case Name: A. v. Thang Botanicals, Inc.
Court Name: District Court, N.D. California
Date Published: Mar 28, 2025
Citation: 3:24-cv-07029
Docket Number: 3:24-cv-07029
Court Abbreviation: N.D. Cal.